NANOVIRICIDES, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NANOVIRICIDES, INC. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $663.80K, a 70.55% decline year-over-year.
- NANOVIRICIDES, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $1.25M, a 27.18% decline year-over-year.
- NANOVIRICIDES, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $604.34K.
- NANOVIRICIDES, INC. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $2.25M.
- NANOVIRICIDES, INC. stock issued during period, value, new issues for fiscal 2025 was $5.30M, a 69.76% increase from fiscal 2024.
- NANOVIRICIDES, INC. stock issued during period, value, new issues for fiscal 2024 was $3.12M.
- NANOVIRICIDES, INC. stock issued during period, value, new issues for fiscal 2022 was $935.09K, a 94.35% decline from fiscal 2021.
- NANOVIRICIDES, INC. stock issued during period, value, new issues for fiscal 2021 was $16.56M, a 0.68% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $663.80K 10-Q · filed 2026-05-15 | |
| 2025-09-30 | $1.25M 10-Q · filed 2026-05-15 | |
| 2025-06-30 | $5.30M 10-K · filed 2025-09-29 | |
| 2025-03-31 | $604.34K 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $2.25M 10-Q · filed 2026-05-15 | |
| 2024-09-30 | $1.71M 10-Q · filed 2026-05-15 | |
| 2024-06-30 | $3.12M 10-K · filed 2025-09-29 | |
| 2022-06-30 | $935.09K 10-K · filed 2023-10-13 | |
| 2021-06-30 | $16.56M 10-K · filed 2022-10-13 | |
| 2021-03-31 | $6.12M 10-Q · filed 2022-05-16 | |
| 2020-09-30 | $10.44M 10-Q · filed 2022-05-16 | |
| 2020-06-30 | $16.68M 10-K · filed 2021-10-12 | |
| 2020-03-31 | $7.46M 10-Q · filed 2021-05-14 | |
| 2019-06-30 | $822.74K 10-K · filed 2021-10-12 | |
| 2019-03-31 | $822.74K 10-Q · filed 2020-06-22 | |
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14 | |
| 2018-09-30 | $5.50M 10-Q · filed 2018-11-14 | |
| 2017-12-31 | $275.00K 10-K · filed 2020-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |